Catalyst
Slingshot members are tracking this event:
Trevena (TRVN) Phase 3 APOLLO-1 and APOLLO-2 Data Evaluating Oliceridine (TRV130) in Moderate to Severe Acute Pain
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TRVN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 21, 2017
Occurred Source:
http://www.trevena.com/news-details.php?id=157
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Apollo-1, Apollo-2, Oliceridine, Moderate-to-severe Acute Pain
